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a  b  s  t  r  a  c  t
Bovine  tuberculosis  (bTB)  remains  a globally  signiﬁcant  veterinary  health  problem.  Deﬁning  correlates
of  protection  can accelerate  the  development  of novel  vaccines  against  TB.  As  the  cultured  IFN ELISPOT
(cELISPOT)  assay  has  been  shown  to predict  protection  and  duration  of immunity  in vaccinated  cattle,  we
sought  to characterize  the  phenotype  of the  responding  T-cells.  Using  expression  of CD45RO  and  CD62L
we  puriﬁed  by cytometric  cell  sorting  four distinct  CD4+ populations:  CD45RO+CD62Lhi, CD45RO+CD62Llo,
CD45RO−CD62Lhi and  CD45RO−CD62Llo (although  due  to  low  and  inconsistent  cell recovery,  this  pop-
ulation  was  not  considered  further  in  this  study),  in BCG  vaccinated  and  Mycobacterium  bovis  infected
cattle.  These  populations  were  then  tested  in the  cELISPOT  assay.  The  main  populations  contributing
to  production  of IFN in  the  cELISPOT  were  of  the  CD45RO+CD62Lhi and  CD45RO+CD62Llo phenotypes.
These  cell  populations  have  been  described  in  other  species  as  central  and  effector  memory  cells,  respec-
tively.  Following  in vitro  culture  and  ﬂow  cytometry  we  observed  plasticity  within  the  bovine CD4+ T-cell
phenotype.  Populations  switched  phenotype,  increasing  or  decreasing  expression  of CD45RO  and  CD62L
within  24 h  of  in vitro  stimulation.  After 14  days  all IFN  producing  CD4+ T cells  expressed  CD45RO
regardless of  the  original  phenotype  of the  sorted  population.  No  differences  were  detected  in behavior
of cells  derived  from  BCG-vaccinated  animals  compared  to cells  derived  from  naturally  infected  animals.
In conclusion,  although  multiple  populations  of  CD4+ T memory  cells  from  both  BCG  vaccinated  and  M.
bovis  infected  animals  contributed  to cELISPOT  responses,  the dominant  contributing  population  consists
of  central-memory-like  T cells  (CD45RO+CD62Lhi).
ht  © 2Crown  Copyrig
. Introduction
Bovine tuberculosis (bTB) has cost the British taxpayer £500
illion over the last decade and it is expected to cost over £1 bil-
ion in the next decade [1], making it one of the most signiﬁcant
eterinary health problems in the U.K. Development of efﬁcacious
accines against TB necessitates a better understanding of pro-
ective immune responses to this disease. Deﬁning correlates of
mmunity can assist in the development of novel vaccines and vac-
ination strategies. The ex vivo ELISPOT measures the frequency of
FN producing cells in PBMCs without prior culture in vitro and it
s considered to be an indicator of the frequency of effector cells.
he cultured IFN ELISPOT (cELISPOT) assay measures long lived
emory T-cell populations, mainly considered to be central mem-
∗ Corresponding author. Tel.: +44 0 1932 359 529; fax: +44 0 1932 357 260.
E-mail address: Bernardo.Villarreal@ahvla.gsi.gov.uk (B. Villarreal-Ramos).
ttp://dx.doi.org/10.1016/j.vaccine.2015.10.113
264-410X/Crown Copyright © 2015 Published by Elsevier Ltd. This is an open access ar
d/4.0/).015  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ory cells, believed to be important for the induction of protection
[2].
In cattle, memory CD4 T-cells have been deﬁned according to
cell surface expression of CD45RO [3–6] and CD62L [5] and more
recently by the expression of CCR7 [7], which is similar to the
deﬁnition of central and effector memory T-cells in humans [8].
CD62L is required for entry into lymph nodes via high endothelial
venules [8] and central memory T-cells are thought to be CD62Lhi
to allow migration to the lymph nodes. In humans, CD45RO+ cells
have shorter telomeres than naïve or CD45RO− T-cells and divide
frequently [9]. Thus, in a generalized simpliﬁed model, central
memory T-cells would be CD45RO+ CD62Lhi; effector memory
cells would be CD45RO+ CD62Llo and naïve cells would be both
CD45RO− CD62Llo/hi. A human study showed that PPD-B speciﬁc
cELISPOT responses were primarily cells expressing surface CCR7
or CD62L, as depletion of these cells dramatically reduced the
cELISPOT response [10]. These data are supported by other stud-
ies that have linked cELISPOT responses to central memory T-cells
[11,12].
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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The cELISPOT has been used to show enhanced Ag85A spe-
iﬁc memory responses after priming with bacille Calmette-Guérin
BCG) and boosting with rAd85A intranasally [13]. cELISPOT
esponses at week 14 post vaccination were predictors of pro-
ection, correlating negatively with the pathology score after
nfection with Mycobacterium bovis [14,15]. Furthermore, cELISPOT
esponses were shown to correlate with duration of protection
gainst M.  bovis in calves vaccinated with BCG [16]. When measured
2 months post-BCG vaccination, the number of PPD-B-speciﬁc
FN spot forming units (SFU) was greater in vaccinated than in
ontrol animals. In contrast, after 24 months post vaccination, no
igniﬁcant difference in PPD-B-speciﬁc IFN SFU was observed in
accinated and control animals, which correlated with a lack of
rotection in vaccinated animals.
Depletion assays have shown that the main producers of IFN,
ollowing stimulation of peripheral blood mononuclear cells from
. bovis infected cattle with mycobacterial antigens, are CD4+ T-
ells [17]; therefore, in this work we have concentrated on studying
he CD4 T-cell response. It has been shown that CD4CD45RO+
nd/or CD4+CD62L+ are capable of producing IFN [4]. However,
he phenotype of the cells producing IFN in terms of central
ersus effector memory remains to be elucidated. In this work we
haracterized the CD45RO and CD62L phenotype of bovine antigen-
peciﬁc CD4+ T-cells responding in the ex vivo and cELISPOT
ystems. We also sought to determine whether the phenotype of
he IFN+ cells remained constant in the culture conditions com-
ared to the originally sorted phenotype. Identiﬁcation of the cells
esponsible for the production of IFN in the cELISPOT will permit
ocusing of efforts to further characterize these cells with the aim
f identifying correlates of protection.
. Materials and methods
.1. Cattle
Animal work was carried out according to the UK Animal (Scien-
iﬁc Procedures) Act 1986. The study protocol was approved by the
HVLA Animal Use Ethics Committee (UK Home Ofﬁce PCD number
0/6905).
Six Holstein–Friesian cross cattle of between 8 and 26 months
f age were used for these experiments; three of these animals
ere vaccinated as neonates with BCG and three were reactors to
he tuberculin skin test and considered naturally infected with M.
ovis. The aim of these experiments was to determine potential dif-
erences in detectable responses in the ex vivo and the cultured IFN
LISPOT between vaccinated and infected animals. The responses
n naïve animals are negligible and therefore were not included in
hese studies.
.2. Preparation of CD4+ cells for sorting
Cattle peripheral blood mononuclear cells (PBMC) were pre-
ared from peripheral blood by gradient density centrifugation and
D4+ T cells were enriched by paramagnetic bead isolation (MACs)
Miltenyi, UK) using monoclonal antibody (mAb) CC8 (IgG2a) to
ovine CD4 (Serotec, UK) as previously described [4]. CD4+ T cells
ere stained with mAbs CC32 (IgG1) to bovine CD62L (AbD Serotec)
nd IL-A116 (IgG3) to CD45RO [3] (a kind gift from Dr Jan Naessens,
LRI), followed by staining with rat mAb  to mouse IgG1: Bril-
iant violet 421 (BD Pharmingen), goat anti-mouse IgG2a: FITC
Southern Biotech), and goat anti-mouse IgG3: R-phycoerythrin
R-PE) (Southern Biotech). After incubation, cells were washed, re-
uspended in RPMI1640 (Gibco) and passed through a 30 m ﬁlter
or sorting. (2015) 7276–7282 7277
Cells were sorted on a Moﬂo Astrios Flow Cytometer (Beck-
man Coulter, USA) at 60 psi with a 70 m nozzle at up to 20,000
events per second, according to the gating strategy shown in
Supplementary Fig. 1 into four populations: CD45RO+ CD62Lhi,
CD45RO+ CD62Llo, CD45RO− CD62Lhi and CD45RO− CD62Llo based
on expression of CD45RO and CD62L. After sorting, individual cell
populations were shown to be >98% pure by ﬂow cytometry.
2.3. Preparation of antigen-presenting cells
CD14 cells were isolated from peripheral blood mononuclear
cells using human CD14+ paramagnetic beads (Miltenyi) according
to manufacturer recommendations. CD14+ cells were used as anti-
gen presenting cells (APC) in ELISPOT assays at a ratio of 1 CD14+
to 10 CD4+ T cells. The purity of the isolated cells ranged from 85%
to 98% (Supplementary Fig. 2)
2.4. Ex vivo IFN ELISPOT
The ex vivo IFN ELISPOT protocol was followed as published
elsewhere [2]. The number of sorted cells was variable and this
in part dictated the number of cells used for the assay; generally,
1–2 × 105 sorted cells were added to each well with APC in a ﬁnal
volume of 200 l in a 96-well round bottom plate. Cells were cul-
tured with medium alone, PPD-B (10 g/ml; APHA, Weybridge) or
pokeweed mitogen (PWM)  (5 g/ml; Sigma) in triplicate, depend-
ing on the number of cells available. Background SFU (unstimulated
cells) was  subtracted and data expressed as mean SFU per 106 cells.
Given the different proportions in which these sub-populations
are represented in PBMC, we  quantiﬁed the contribution of each
subpopulation to ex vivo ELISPOT. SFU were multiplied by the ratio
of originally sorted cells (O) divided by the number of cells put into
culture (d0) to obtain eSO1 to eSO4 i.e. eSO1. . .4  = eSFU1.  . .4  * O/d0.
This ﬁgure was  added for all populations, eSO1 + eSO2 + eSO3 + cSO4,
and used as total potential SFU (eSOt) of the original CD4 population
i.e. eSOt = eSO1 + eSO2 + eSO3 + eSO4. To obtain the proportion of SFU
that each individual cell population would have contributed (eSP),
each individual SO was divided by the SOt and multiplied by 100
i.e. eSP1.4 = (eSO1.4/eSOt) * 100.
2.5. Evaluation of cytokine responses by intracellular staining
(ICS)
ICS was  performed as previously described [18]. Cells were sur-
face stained for CD4, CD45RO (IL-A116) and CD62L (CC32) and
intracellularly for IFN (CC302). Cells were acquired using a Cyan
ADP analyser and Summit 4.3 software (Beckman Coulter, USA).
Data were analyzed using FlowJo v7.6.5 software (Treestar, USA).
2.6. Cultured IFN ELISPOT
Sorted T-cell populations were cultured for 2 weeks as described
elsewhere [2], using PPD-B and fed IL-2 at days 3 and 7 and medium
replaced on days 10 and 12. After 14 days, intracellular staining and
ELISPOT assays were performed as above. In the cELISPOT, to avoid
saturation, 1 × 103 cells were used per well in the assay.
To determine the contribution of each cell population to
the cELISPOT the number of SFU (S) was multiplied by the
ratio of cells obtained at 14 days and divided by the num-
ber of cells with which the cultures were started (d14/d0) i.e.
cSO1. . .4 = (cSFU1.4 * d14/d0) * O/dO; this would provide the SFU
related to the originally cultured cells. To obtain a relationship
of this ﬁgure to the number of cells sorted for each population
this ﬁgure was multiplied by the ratio of the total number of
cells sorted for each population (O) divided by the number of
cells placed into culture at day 0 (d0). This ﬁgure would provide
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Fig. 1. The majority of peripheral blood CD4+ T-cells exhibit a CD45RO+CD62Llo
phenotype. CD4+ cell populations were sorted according to their expres-
sion of cell surface CD45RO and CD62L using the gating strategy described
in  Supplementary Fig. 1. CD4+ T-cells were sorted into CD45RO+CD62Lhi,
CD45RO+CD62LloCD45RO−CD62Lhi and CD45RO−CD62Llo. The largest proportion
of  CD4+ T-cells in all animals expressed the phenotype CD45RO+ CD62Llo. No sig-
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Ciﬁcant difference between BCG vaccinated (dark symbols) and M. bovis infected
clear symbols) animals was  observed in the proportions of CD4+ T-cell as deﬁned
y  CD45RO and CD62L.
he number of SFU formed had all originally sorted cells been
laced into culture (cSO). This ﬁgure was added for all populations
cSO1 + cSO2 + cSO3 + cSO4) and used as total potential SFU (cSOt)
f the original CD4 population, i.e. cSOt = cSO1 + cSO2 + cSO3 + cSO4.
o obtain the proportion of SFU that each individual cell population
ould have contributed (cSP), each individual SO was  divided by
he SOt and multiplied by 100 (i.e. cSP1.4 = (cSO1.4/cSOt) * 100).
.7. Statistical analysis
Statistical analysis and graph creation were carried out using
raphPad Prism 5.02 (GraphPad Software, CA. USA) employing
-way Anova or Student’s t-test analysis. p values <0.05 were con-
idered signiﬁcant.
. Results
.1. The proportion of peripheral blood CD4+ cells expressing the
emory associated markers CD45RO+ CD62Llo is higher than the
roportion of CD45RO+ CD62Lhi, CD45RO−CD62Lhi and
D45RO−CD62Llo
Flow cytometry analysis of CD4+ populations prior to sorting
evealed that the majority of cells expressed cell surface CD45RO.
upplementary Fig. 1 shows the gating strategy used for the sorting
f the four different CD4+ T-cell populations, based on expres-
ion of cell surface markers CD45RO and CD62L. These sorted
ell populations were used for all subsequent experiments. Fig. 1
hows the proportions of the different cell populations found in
he BCG vaccinated and M.  bovis infected animals after sorting. The
ajority (mean of 74.13%) of ex vivo CD4+ T-cells were CD45RO+
D62Llo in both BCG vaccinated and TB reactor animals (Fig. 1).
he rarest population was the CD45RO− CD62lo cells. As a propor-
+ion of the total sorted CD4 T-cells, the different cell populations
ere: CD45RO− CD62lo cells 1.14–4.46%; CD45RO+ CD62Llo T-
ells 66.85–83.29%; CD45RO+ CD62Lhi T-cells 8.05–11.84%; and
D45RO− CD62Lhi T-cells 5.94–20.45%. There was  no signiﬁcant (2015) 7276–7282
difference of the different CD4+ T-cells subpopulations between
BCG vaccinated and naturally M.  bovis infected cattle. Due to the
small number of CD45RO−CD62Llo cells isolated, it was not possible
to analyze their responses in the studies described below.
3.2. CD45R0+CD62Lhi, CD45R0+CD62Llo and CD45R0−CD62Lhi,
all contain IFN precursors, although their contribution is
variable in the ex vivo and cELISPOT
Sorted cells were stimulated in vitro to determine the frequency
of IFN secreting cells in the ex vivo ELISPOT and cELISPOT assays,
after 1 or 14 days of in vitro culture, respectively. Fig. 2 shows that
cells within all populations are capable of secreting IFN following
antigen speciﬁc stimulation for 24 h (Fig. 2A) or 14 days (Fig. 2B)
in vitro, from both BCG vaccinated and M.  bovis infected cattle.
In the ex vivo ELISPOT, M. bovis infected animals contained the
highest frequency of IFN producing cells in all populations com-
pared to BCG vaccinated animals. The highest number of IFN
producing cells was detected in the CD45RO+CD62Lhi population
followed by the CD45RO+CD62Llo and then the CD45RO−CD62Lhi
populations.
In the cELISPOT the differences in the frequencies of IFN secret-
ing cells in the different populations between M. bovis infected and
BCG vaccinated animals were less evident. All cell populations con-
tained similar frequencies of IFN+ cells from M.  bovis infected and
BCG vaccinated animals. In conclusion, all three sub-populations
studied were able to respond in both assays on a qualitative, cell-
by-cell, basis.
Given the different proportions in which these three sub-
populations are present in PBMC, we  quantiﬁed the subset
contribution of each subpopulation to the ex vivo ELISPOT and
cELISPOT. The contribution of each subpopulation to the overall
ex vivo and cELISPOT responses is shown in Fig. 3A and B. The
CD4+CD45RO+CD62Lhi T cell subpopulation expanded on average
3.52 fold (±4.14) during the 14 day culture (expansion meaning the
net effect of cell growth and cell death during the culture phase),
whilst the other two  populations contracted CD45RO+CD62Llo
(0.88 ± 0.63) and CD45RO−CD62Lhi (0.62 ± 0.38) during culture.
The highest response in the ex vivo ELISPOT resided within
the CD45RO+CD62Llo population in both M.  bovis infected and
BCG vaccinated animals, followed by the CD45RO+CD62Lhi pop-
ulation (Fig. 3A); the proportion of IFN secreting cells in the
CD45RO−CD62Lhi cells was minimal. In contrast, in the cELISPOT,
the highest response resided within the CD45RO+CD62Lhi popu-
lation (Fig. 3B); both the CD45RO+CD62Llo and CD45RO−CD62Lhi
populations, respectively, contained fewer IFN secreting cells.
3.3. The expression of the CD45RO and CD62L phenotype of CD4+
T cells exhibits a degree of plasticity during in vitro culture
We  also investigated the in vitro dynamics of CD45RO and CD62L
expression after short (24 h) and long term (14 d) culture. After cul-
ture, cells were re-stimulated and cell surface antigen expression
and IFN production determined by ICS-cytometry. Fig. 4 presents
the results from a representative BCG vaccinated animal. As early as
24 h in culture, the expression of both CD45RO and CD62L changed
in all three populations, with a proportion of CD45RO+CD62Lhi
cells acquiring a CD62Llo phenotype, whilst a proportion of
CD45RO+CD62Llo cells acquired a CD62Lhi phenotype. A small pro-
portion of these cells also became CD45RO−CD62Lhi. Finally, small
proportions of CD45RO−CD62Lhi cells became CD45RO+CD62Lhi or
CD45RO+CD62Llo (Fig. 4).Greater plasticity in the expression of these markers was
observed after a longer culture period. All cells producing
IFN after antigenic re-stimulation after 14 day culture, regard-
less of the input cell population phenotypes at the beginning
L. Blunt et al. / Vaccine 33 (2015) 7276–7282 7279
Fig. 2. All, CD45R0+CD62Lhi , CD45R0+CD62Llo and CD45R0−CD62Lhi , CD4 populations contain IFN secreting precursors. The frequency of IFN secreting cells from each
sorted  phenotype was evaluated in IFN ex vivo ELISPOT after 24 h (A) or cELISPOT after 14 days in culture (B) in BCG vaccinated (dark columns) and M.  bovis infected (white
columns) animals. CD45RO−CD62Llo sorted cells were excluded from the analysis due to an insufﬁcient number of cells. Data are representative of three experiments with
CD4+ T-cells from three cattle. Results are expressed as the mean SFU/106 cells ±SEM.
Fig. 3. The main contributors to the ex vivo ELISPOT are CD45RO+CD62lo, whilst CD45RO+CD62Lhi are the main contributors to the cELISPOT. Using the data from Fig. 2, the
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nfected (white columns) animals.
f in vitro culture (CD45RO+CD62Lhi, CD45RO+CD62Llo, or
D45RO−CD62Lhi), expressed CD45RO. Whilst the majority of
D45RO+CD62Lhi and CD45RO+CD62Llo retained stable CD62L
xpression, substantial proportions of the CD45RO+CD62Lhi
ecreased expression to become CD62Llo, whilst a substantial
roportion of CD45RO+CD62Llo increased expression to become
D62Lhi (Fig. 5). The most dramatic in vitro dynamics in CD45RO
nd CD62L expression were displayed by the antigen-speciﬁc IFN+
D45RO−CD62Lhi subpopulation Not only did these cells express
D45RO after 2 weeks in culture, but the majority also decreased
xpression of CD62L to become CD62Llo (Fig. 5). These results
learly demonstrate that it is difﬁcult to draw conclusions on the
ature of memory cell responses using expression of the markers
D45RO and CD62L after in vitro culture.
. Discussion
The IFN cELISPOT has been proposed as a predictor of protec-
ion against bTB and duration of immunity in BCG or BCG/subunit
accine heterologous prime-boost vaccination of cattle [15]. How-
ver, the nature of the cells producing IFN in this assay has
ot been deﬁned. The phenotype of memory T-cell responses to
ycobacteria in cattle has previously been deﬁned in terms ofulas described in materials and methods and plotted to show the extent to which
o ELISPOT (A) and cELISPOT (B) for BCG vaccinated (black columns) and M.  bovis
CD45RO and CD62L [15] and we therefore wanted to character-
ize the cells responding in the cELISPOT using these markers. The
results presented in this study indicate that CD4+ T cells with
both the central memory-associated phenotype CD45RO+CD62Lhi,
and effector memory-associated phenotype CD45RO+CD62Llo are
involved in the IFN ex vivo ELISPOT and cELISPOT response in cattle
In humans, cells responding in the cELISPOT to hepatitis C virus
have been deﬁned as predominantly CD4+CCR7+CD62Lhi T cells
and less frequent CD4+CCR7−CD62Llo populations [10] [11]. CD62L
and CCR7 expression is required for cell extravasation through
high endothelial venules (HEV) to enable migration from blood
to secondary lymphoid organs, which is thought to be a charac-
teristic of central memory cells [8,19,20]. We have not evaluated
CCR7 expression in the present study. However, a recent study has
described that the populations of CD4+ T cells expressing high lev-
els of CD62L (CD62Lhi) largely overlap with those expressing CCR7
(Waters et al., pers. comm.).
On a cell by cell basis, CD45RO+CD62Lhi and CD45RO+CD62Llo
cells contribute to a similar extent to the ex vivo and cELISPOT; how-
ever, as a proportion of overall responses, CD45RO+CD62Lhi cells
dominate the cELISPOT compared to CD45RO+CD62Llo cells. This
would be consistent with central memory functionality of cELISPOT
IFN secreting cells. In contrast, CD45RO+CD62Llo contributed to a
greater extent to the ex vivo ELISPOT compared to CD45RO+CD62Lhi
7280 L. Blunt et al. / Vaccine 33 (2015) 7276–7282
Fig. 4. All, CD45R0+CD62Lhi , CD45R0+CD62Llo and CD45R0−CD62Lhi , CD4 populations exhibit plasticity on their expression of their originally deﬁning cell surface markers.
Representative ﬂow cytometric analysis of the different cell populations after sorting (0 h) or after culture for 24 h or 14 days. CD4+ T-cells expressing CD62L and CD45RO
were  stained as described in materials and methods.
Fig. 5. All IFN producing cells, after 14 days culture are CD45RO+, regardless of the starting population. The proportion of IFN secreting cells which switched to
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cD45RO+CD62Llo or CD45RO+CD62Lhi after 14 days in vitro culture in M. bovis-in
ls  and methods. The individual bars denote the phenotype of input cells and data ar
ean  percentage of CD4+ cells producing IFN ± SEM. N.D. There were not sufﬁcien
ells, which would be consistent with effector function. There-
ore, the current data indicate that CD45RO and CD62L could
ontribute in the deﬁnition and characterization of memory cell
opulations.
In this work we have also shown that within the different CD4+
ell populations some cells show a degree of plasticity as they (A) and BCG vaccinated (B) cattle were measured by ICS as indicated in materi-
esentative of three experiments with CD4+ T-cells from three cattle. Results are the
ber of CD45RO−CD62Lhi cells in M. bovis infected animals to carry out this assay.
switch phenotype by up- or down-regulating CD45RO and CD62L
within 24 h of in vitro stimulation. Such plasticity has been observed
in other CD4 T cell subsets, such as the ability of Tregs to become
Th17 cells [21,22] and of Th17 cells to exhibit Th1 characteristics
i.e. to switch to dominant IFN expression from dominant IL-17
expression [23].
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After 14 days culture, the majority of CD4+ cells from all animals
ere CD45RO+ regardless of CD62L expression status. Therefore, it
s difﬁcult to undertake phenotype-functionality evaluation of ex
ivo sorted subsets by phenotyping cells after even a short in vitro
timulation period; this demonstrates that to determine the contri-
ution of in vivo generated T cell memory subsets to the outcome of
unctional assays, these subsets need to be puriﬁed prior to culture.
Production of IFN was observed mainly in CD45RO+ cells,
hich is supported by another study which found that sorted CD4+
D45RO+, but not CD4+ CD45RO− T-cells produced IL-4 and IFN
ranscripts as well as biologically active IFN in bovine T-cells [24].
his further supports the view that CD45RO expression relates to
n activation/memory state for T-cells [25].
In this study, no difference was detected in the ability of cells
erived from M.  bovis infected animals or from BCG-vaccinated ani-
als to respond in the IFN ex vivo ELISPOT or cELISPOT assays. This
s not surprising and needs to be viewed in the context of timing.
accine-induced responses were measured before infection and
hus reﬂect the effect of vaccination, whilst the responses in the
nfected animals were measured after the infection had been estab-
ished. Responses to infection in naïve animals would be delayed
ompared to responses in vaccinated and infected animals [26];
esponses in naïve animals after infection would be less likely to
ontrol or clear the infection, whilst responses in vaccinated ani-
als would be more likely to control mycobacteria. Further, the
. bovis infected cattle in our study were without clinical mani-
estations of the disease and can therefore be viewed as latent or
ith very slow progressing disease and with low bacterial loads
hat could allow central memory development. It is likely that dis-
ase progression leading to increased bacillary/antigen load would
ead to exhaustion of this memory pool due to constant stimu-
ation without antigenic clearance. Several vaccine studies with
attle have demonstrated that memory responses are positive cor-
elates of protection as they negatively correlate with TB-associated
athology [15,16] and mycobacterial burden [27]. The cELISPOT
esponse correlates with slow disease progression in natural infec-
ion [28]. It has been shown that during active replication, effector
-cells are expanded and memory cells are detectable after control
r eradication [28,29].
In summary, the central or effector memory function of bovine
D4+ T-cells, as evaluated in the ex vivo ELISPOT and cELISPOT
an be deﬁned by the surface markers CD45RO and CD62L. Fur-
hermore, due to the plasticity in the expression of these cell
urface markers, it would be difﬁcult to directly correlate what is
bserved ex vivo in blood or peripheral blood mononuclear cells
irectly to what is observed after a period of culture. This correla-
ion can only be achieved by deﬁning the ex vivo population prior to
ulture.
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